# Effect of GLP-1 and GIP on Insulin Secretion in Type-1 Diabetes Mellitus

> **NCT00603031** · NA · COMPLETED · sponsor: **Hvidovre University Hospital** · enrollment: 9 (actual)

## Conditions studied

- Type-1 Diabetes Mellitus

## Interventions

- **OTHER:** glucagon like peptide -1
- **OTHER:** NaCl
- **OTHER:** glucose dependent insulinotropic polypeptide

## Key facts

- **NCT ID:** NCT00603031
- **Lead sponsor:** Hvidovre University Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-01
- **Primary completion:** 2008-06
- **Final completion:** 2008-06
- **Target enrollment:** 9 (ACTUAL)
- **Last updated:** 2011-01-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00603031

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00603031, "Effect of GLP-1 and GIP on Insulin Secretion in Type-1 Diabetes Mellitus". Retrieved via AI Analytics 2026-07-02 from https://api.ai-analytics.org/clinical/NCT00603031. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*